• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在临床中使用患者报告结局来衡量症状及与健康相关的生活质量。

Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic.

作者信息

Gilbert Alexandra, Sebag-Montefiore David, Davidson Susan, Velikova Galina

机构信息

MRCP, University of Leeds, UK.

FRCR FRCP, University of Leeds, UK.

出版信息

Gynecol Oncol. 2015 Mar;136(3):429-39. doi: 10.1016/j.ygyno.2014.11.071. Epub 2014 Nov 28.

DOI:10.1016/j.ygyno.2014.11.071
PMID:25448486
Abstract

There is increasing interest in the use of patient-reported outcomes (PROs) in routine practice in cancer care to measure symptoms and health related quality of life (HRQOL). PROs are designed to capture the patient's perspective of their care and treatment, and complement the traditional clinical outcomes of survival and toxicity assessment. Integrating routine collection and feedback of PROs has been found to improve care for patients on both an individual level, through improved communication and management of symptoms, and at an organizational level, by enabling aggregation of data to compare performance. This article reviews the benefits and challenges of introducing patient-reported assessments into routine clinical practice. Methods for choosing a questionnaire; collection and presentation of results; timing and frequency of administration as well as clinician training methods to aid the ability of clinicians to integrate the use of PROs into their own practice are described. Electronic PRO capture and integration with electronic health records seems to provide the most effective method for seamless integration into existing patient care pathways. Case studies from our own practice illustrate the issues raised. Electronic methods enabling immediate collection, scoring and interpretation of the data, as well as real-time data capture, email alert systems and individualized, online self-management advice may enable severe symptoms to be managed in a more timely manner. Evaluation methods are described to establish the effectiveness of the PRO intervention. Engaging stakeholders throughout the process of initial consultation and development, during delivery and evaluation is key to success. Future work needs to focus on the effectiveness of PROs in longer-term follow-up of patients in routine care and the relationship between the PRO severity grading and clinician severity grading using the Common Terminology Criteria of Adverse Events (CTCAE).

摘要

在癌症护理的常规实践中,使用患者报告结局(PROs)来衡量症状和健康相关生活质量(HRQOL)的兴趣日益浓厚。PROs旨在获取患者对其护理和治疗的看法,并补充生存和毒性评估等传统临床结局。已发现整合PROs的常规收集和反馈,在个体层面上通过改善症状的沟通和管理来改善患者护理,在组织层面上通过汇总数据以比较绩效来实现。本文综述了将患者报告评估引入常规临床实践的益处和挑战。描述了选择问卷的方法、结果的收集和呈现、施测的时间和频率,以及帮助临床医生将PROs的使用整合到自身实践中的临床医生培训方法。电子PRO捕获以及与电子健康记录的整合似乎为无缝整合到现有的患者护理路径中提供了最有效的方法。我们自身实践中的案例研究说明了所提出的问题。能够立即收集、评分和解释数据的电子方法,以及实时数据捕获、电子邮件警报系统和个性化的在线自我管理建议,可能使严重症状得到更及时的管理。描述了评估方法以确定PRO干预的有效性。在初始咨询、开发、实施和评估的整个过程中让利益相关者参与是成功的关键。未来的工作需要关注PROs在常规护理中对患者长期随访的有效性,以及使用不良事件通用术语标准(CTCAE)的PRO严重程度分级与临床医生严重程度分级之间的关系。

相似文献

1
Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic.在临床中使用患者报告结局来衡量症状及与健康相关的生活质量。
Gynecol Oncol. 2015 Mar;136(3):429-39. doi: 10.1016/j.ygyno.2014.11.071. Epub 2014 Nov 28.
2
The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.基于互联网的电子学习对临床医生行为和患者结局的有效性:一项系统评价方案。
JBI Database System Rev Implement Rep. 2015 Jan;13(1):52-64. doi: 10.11124/jbisrir-2015-1919.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.整合患者报告结局在临床实践和绩效评估中的应用:来自三个国家的专家观点
Milbank Q. 2014 Dec;92(4):754-75. doi: 10.1111/1468-0009.12091.
6
AMCP Partnership Forum: Improving Quality, Value, and Outcomes with Patient-Reported Outcomes.AMCP 合作论坛:利用患者报告的结局改善质量、价值和结果。
J Manag Care Spec Pharm. 2018 Mar;24(3):304-310. doi: 10.18553/jmcp.2018.17491. Epub 2018 Feb 20.
7
Improving an electronic system for measuring PROs in routine oncology practice.改进电子系统,以在常规肿瘤学实践中测量 PROs。
J Cancer Surviv. 2016 Jun;10(3):573-82. doi: 10.1007/s11764-015-0503-6. Epub 2015 Dec 7.
8
PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study.癌症患者临床应用中患者报告结局评估的亲肿瘤选择——一项混合方法多中心横断面探索性研究
Support Care Cancer. 2016 Jun;24(6):2503-12. doi: 10.1007/s00520-015-3055-4. Epub 2015 Dec 16.
9
The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care.技术进步在临床护理中采用和整合患者报告结局方面的作用。
Med Care. 2015 Feb;53(2):153-9. doi: 10.1097/MLR.0000000000000289.
10
Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice).参与癌症化疗期间不良反应在线报告的患者和临床医生:eRAPID 系统(电子患者自我报告不良反应:患者信息和建议)。
Med Care. 2019 May;57 Suppl 5 Suppl 1:S59-S65. doi: 10.1097/MLR.0000000000001085.

引用本文的文献

1
'Beyond Treatment': Clinical and psychosocial predictors of health-related quality of life of patients with prostate cancer.“超越治疗”:前列腺癌患者健康相关生活质量的临床及社会心理预测因素
SAGE Open Med. 2025 Jul 24;13:20503121251360120. doi: 10.1177/20503121251360120. eCollection 2025.
2
Gut Microbial Signatures in Long COVID: Potential Biomarkers and Therapeutic Targets.长新冠中的肠道微生物特征:潜在的生物标志物和治疗靶点。
Infect Dis Ther. 2025 Jun 1. doi: 10.1007/s40121-025-01167-6.
3
Revision tracheal resection anastomosis for recurrent stenosis after airway surgeries: functional outcomes.
气道手术后复发性狭窄的气管切除吻合术修订:功能结果
Eur Arch Otorhinolaryngol. 2025 May 20. doi: 10.1007/s00405-025-09441-6.
4
The problem of missing data for learning health systems focused on first-episode psychosis.针对首发精神病的学习型健康系统中的数据缺失问题。
Schizophr Res. 2025 May;279:79-86. doi: 10.1016/j.schres.2025.03.021. Epub 2025 Apr 2.
5
Strategies to promote the completion of patient-reported outcome measures by culturally and linguistically diverse and Indigenous Peoples in clinical care settings: A systematic review.促进临床护理环境中文化和语言多样化人群及原住民完成患者报告结局测量的策略:一项系统评价
Qual Life Res. 2025 Feb 8. doi: 10.1007/s11136-025-03913-2.
6
Using voice recognition and machine learning techniques for detecting patient-reported outcomes from conversational voice in palliative care patients.使用语音识别和机器学习技术从姑息治疗患者的对话语音中检测患者报告的结果。
Jpn J Nurs Sci. 2025 Jan;22(1):e12644. doi: 10.1111/jjns.12644.
7
Impact of immigration background on feasibility of electronic patient-reported outcomes in advanced urothelial cancer patients.移民背景对晚期尿路上皮癌患者电子患者报告结局可行性的影响。
Health Qual Life Outcomes. 2024 Dec 18;22(1):107. doi: 10.1186/s12955-024-02325-z.
8
Acceptability and timing considerations when administering patient-reported outcome measures (PROMs) among people with chronic health conditions who are culturally and linguistically diverse (CALD): a qualitative study protocol.患有慢性健康状况且文化和语言多样化(CALD)人群中使用患者报告结局测量(PROMs)时的可接受性和时间考虑因素:一项定性研究方案。
BMJ Open. 2024 Sep 12;14(9):e083346. doi: 10.1136/bmjopen-2023-083346.
9
Development and Psychometric Validation of Patient-Reported Outcome Measures (PROMs BCC-20) for Assessing Comfort during Chemotherapy in Breast Cancer Patients.用于评估乳腺癌患者化疗期间舒适度的患者报告结局测量量表(BCC-20)的制定和心理测量学验证。
Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2799-2807. doi: 10.31557/APJCP.2023.24.8.2799.
10
Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice.卵巢癌患者报告结局:促进和加强临床试验及临床实践中症状、不良事件和治疗主观获益的报告
Patient Relat Outcome Meas. 2023 May 8;14:111-126. doi: 10.2147/PROM.S297301. eCollection 2023.